AlloVir Inc (ALVR)
0.7583
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 11:20
AlloVir Cash from Operations (TTM): -124.45M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -124.45M |
September 30, 2023 | -125.29M |
June 30, 2023 | -125.94M |
March 31, 2023 | -127.69M |
December 31, 2022 | -142.05M |
September 30, 2022 | -138.55M |
June 30, 2022 | -139.86M |
March 31, 2022 | -133.87M |
December 31, 2021 | -106.32M |
Date | Value |
---|---|
September 30, 2021 | -99.34M |
June 30, 2021 | -80.96M |
March 31, 2021 | -69.19M |
December 31, 2020 | -60.81M |
September 30, 2020 | -48.59M |
June 30, 2020 | -36.93M |
March 31, 2020 | -28.72M |
December 31, 2019 | -20.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-142.05M
Minimum
Dec 2022
-20.16M
Maximum
Dec 2019
-94.63M
Average
-106.32M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Karuna Therapeutics Inc (DELISTED) | -385.82M |
Arcutis Biotherapeutics Inc | -247.06M |
Reviva Pharmaceuticals Holdings Inc | -24.14M |
CEL-SCI Corp | -23.07M |
AIM ImmunoTech Inc | -17.58M |